Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β 2 -Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β 2 -Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score-Inverse Probability of Treatment Weighting Cohort Study

Despite multiple available fixed-dose combinations (FDCs) of inhaled long-acting β -agonists (LABAs) plus long-acting muscarinic antagonists (LAMAs) and LABAs plus inhaled corticosteroids (ICS) for COPD, uncertainty remains regarding their comparative effects. Can comparative effectiveness and safet...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Chest 2021-10, Vol.160 (4), p.1255
Hauptverfasser:	Wang, Meng-Ting, Lai, Jyun-Heng, Huang, Ya-Ling, Liou, Jun-Ting, Cheng, Shih-Hsuan, Lin, Chen Wei, Pan, Hsueh-Yi, Hsu, Yu-Juei, Tsai, Chen-Liang
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Inhalation Adrenergic beta-2 Receptor Agonists - therapeutic use Aged Beclomethasone - therapeutic use Benzyl Alcohols - therapeutic use Budesonide, Formoterol Fumarate Drug Combination - therapeutic use Chlorobenzenes - therapeutic use Cohort Studies Comparative Effectiveness Research Disease Progression Drug Combinations Female Fluticasone-Salmeterol Drug Combination - therapeutic use Formoterol Fumarate - therapeutic use Glucocorticoids - therapeutic use Glycopyrrolate - analogs & derivatives Glycopyrrolate - therapeutic use Humans Indans - therapeutic use Male Muscarinic Antagonists - therapeutic use Pneumonia - epidemiology Propensity Score Proportional Hazards Models Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Disease, Chronic Obstructive - physiopathology Quinolones - therapeutic use Quinuclidines - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!